19330590

Source:http://linkedlifedata.com/resource/pubmed/id/19330590

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0031809, umls-concept:C0035647, umls-concept:C0087111, umls-concept:C0165519, umls-concept:C1956346
pubmed:issue	2
pubmed:dateCreated	2009-3-30
pubmed:abstractText	Matrix metalloproteinase (MMP)-9, a member of the MMP superfamily is consistently implicated in the pathophysiology of atherosclerosis and plaque rupture, the most common mechanism responsible for acute coronary syndrome (ACS).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9606000
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 9, http://linkedlifedata.com/resource/pubmed/chemical/Protease Inhibitors
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1366-5804
pubmed:author	pubmed-author:AielloRobert JRJ, pubmed-author:FryburgDavid ADA, pubmed-author:KonstantinoYuvalY, pubmed-author:NguyenTu TTT, pubmed-author:TerraSteven GSG, pubmed-author:WolkRobertR
pubmed:issnType	Electronic
pubmed:volume	14
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	118-29
pubmed:meshHeading	pubmed-meshheading:19330590-Animals, pubmed-meshheading:19330590-Coronary Artery Disease, pubmed-meshheading:19330590-Humans, pubmed-meshheading:19330590-Matrix Metalloproteinase 9, pubmed-meshheading:19330590-Mice, pubmed-meshheading:19330590-Protease Inhibitors, pubmed-meshheading:19330590-Risk Factors
pubmed:year	2009
pubmed:articleTitle	Potential implications of matrix metalloproteinase-9 in assessment and treatment of coronary artery disease.
pubmed:affiliation	Cardiovascular and Metabolic Diseases, Pfizer Global Research and Development, Groton, CT, USA. yuvkon@gmail.com
pubmed:publicationType	Journal Article